Francis J. Martin

NMT Medical, Inc. is an advanced medical technology company. It designs, develops, manufactures and markets proprietary implant technologies that allow interventional cardiologists to treat structural heart disease through minimally invasive, catheter-based procedures. The company was founded in July 1986 and is headquartered in Boston, MA

CytoDome, Inc.manufactures implantable devices for medical treatment. The company provides treatment for diseases of the central nervous system by way of sustained release of therapeutic & diagnostic substances with ever-larger molecules. It was founded by Gill Heart in July, 2003 and is located in Atlanta, GA.

Cappella, Inc. operates as a medical device company, which develops novel solutions for the treatment of complex coronary artery disease (CAD) and specifically bifurcation vascular disease. The company was founded by Antonio Columbo and Ascher Shmulewitz in 2004 and is headquartered in Boston, MA.

Corindus, Inc. designs, manufactures and commercializes precision vascular robotic systems for use in minimally invasive procedures. The Company’s initial product, the CorPath system, provides procedure control from an interventional cockpit, allowing for precise, robotic-assisted placement of coronary guidewires and stent/balloon catheters.

Part of American Heart Association, Inc., American Heart Association (New York) provides public health educational services. The company is based in New York, NY.